Ebola outbreak in eastern Congo spreads to 2 new health zones with a total of 60 areas now affected

The fastest-growing Ebola outbreak in history has expanded to two new health zones, Biena and Manguredjipa, in eastern Congo's North Kivu province, bringing the total affected areas to 60. The outbreak, which began in mid-May but is believed to have been spreading since February, has recorded 5,794 confirmed cases and 2,786 deaths. The case fatality rate in North Kivu is higher than the overall 48% due to delayed response efforts and difficult conditions including insecurity and displacement. Congo began vaccinating health workers with the Ervebo vaccine, though clinical trials are ongoing for a vaccine against the specific Bundibugyo virus causing this outbreak. Efforts to control the spread, including public gathering limitations and airport closures, have disrupted life in the six affected provinces.

The Democratic Republic of Congo (DRC) has commenced vaccinating front-line healthcare workers against Ebola to combat a deadly outbreak. While over 50,000 doses of the Ervebo vaccine have been received, it is licensed for a different strain, and its effectiveness against the current Bundibugyo strain is undetermined. Clinical trials are underway to find a suitable vaccine for this new strain, for which there is currently no approved treatment. The vaccination drive, prioritizing health workers in Kisangani and surrounding provinces, aims to control the outbreak concentrated in Ituri province. The DRC has recorded 5,713 confirmed cases and 2,744 deaths, making this the deadliest Ebola outbreak in its history, exacerbated by insecurity and population movements.

The Democratic Republic of Congo has initiated an Ebola vaccination campaign to combat a significant outbreak. This effort aims to address the deadliest outbreak of the virus. The campaign's launch signifies a proactive measure by the Congolese government to control and mitigate the spread of Ebola. The primary objective is to protect the population and curb the ongoing epidemic.

Congo has initiated an Ebola vaccination campaign in Kisangani, Tshopo province, to combat its deadliest outbreak on record. Health workers and frontline responders are prioritized for the Ervebo vaccine. The outbreak has spread across six provinces, resulting in 5,713 confirmed cases and 2,744 deaths as of Tuesday, with a 48% mortality rate. The campaign faces challenges due to insecurity and population movements. Over 50,000 doses of the Ervebo vaccine have arrived, with 70,000 approved for use. While Ervebo is approved for Zaire ebolavirus, it is being used under a compassionate-use program for the current Bundibugyo Ebola outbreak, as the viruses are related and it may offer some protection. Data will be collected to assess the vaccine's effectiveness.